Solid Biosciences Inc. SLDB Operating cash flows from finance leases
Operating cash flows from finance leases at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseInterestPaymentOnLiability.
The official record: Solid Biosciences Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s operating cash flows from finance leases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s operating cash flows from finance leases?
- Solid Biosciences Inc. (SLDB) reported operating cash flows from finance leases of $22.75K in Q4 2025.
- How has Solid Biosciences Inc.'s operating cash flows from finance leases changed year-over-year?
- Solid Biosciences Inc.'s operating cash flows from finance leases decreased by 80.6% year-over-year, from $117.25K to $22.75K.
- What is the long-term trend for Solid Biosciences Inc.'s operating cash flows from finance leases?
- Over 2 years (2023 to 2025), Solid Biosciences Inc.'s operating cash flows from finance leases has grown at a -50.7% compound annual growth rate (CAGR), from $375K to $91K.
- What does operating cash flows from finance leases mean?
- Represents the cash interest portion paid on liabilities associated with finance leases. This metric helps investors isolate the cost of financing leased assets from the principal repayment, providing clarity on the company's debt-servicing burden.